Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer

NCT06654622 · clinicaltrials.gov ↗
COMPLETED
Status
175
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

City of Hope Medical Center